Concepedia

Fabian Heider

FH

4

Publications

136

Citations

4

H-Index

2017

Active since

Affiliations

University of Tübingen(Current)

University Children's Hospital Tübingen

MetrioPharm (Germany)

University of Regensburg

University of Eastern Finland

Fabian Heider is an author at University of Tübingen specializing in drug development, drug discovery, and cellular biochemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryChemical BiologyDrug DevelopmentNatural SciencesCellular BiochemistryMolecular Pharmacology

Publications per year

2017–2019

4

Publications

4

Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs

M. Tobias Heinrichs, RobertJustin May, Fabian Heider et al. · International Journal of Mycobacteriology · 2018 · 77 citations · Full text

Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors

Fabian Heider, Francesco Ansideri, Roberta Tesch et al. · European Journal of Medicinal Chemistry · 2019 · 30 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +9

Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks

Fabian Heider, Tatu Pantsar, Mark Kudolo et al. · ACS Medicinal Chemistry Letters · 2019 · 17 citations · Full text

From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors

Fabian Heider, Urs Haun, Eva Döring et al. · Molecules · 2017 · 12 citations · Full text

Rows per page

1–4 of 4